Saturday, February 01, 2025 | 04:18 AM ISTEN Hindi
Business Standard
Notification Icon
userprofile IconSearch

Page 5 - Medicines

South Korea to send non-lethal military and medical supplies to Ukraine

The South Korean government announced on the 15th that it will send non-lethal military supplies to Ukraine, which is fighting against Russia's invasion

South Korea to send non-lethal military and medical supplies to Ukraine
Updated On : 16 Mar 2022 | 1:53 PM IST

Govt's Jan Aushadi programme to exceed 2021-22 targets, shows data

The pace is slower for including more medicines in the product basket; sales have grown at a CAGR of 51.9% in the last five years

Govt's Jan Aushadi programme to exceed 2021-22 targets, shows data
Updated On : 03 Mar 2022 | 6:10 AM IST

India to send urgent relief supplies, including medicines to Ukraine

Ambassador of India to the United Nations, T S Tirumurti, on Monday said that India has decided to provide urgent relief supplies, including medicines to Ukraine, expected to be dispatched tomorrow

India to send urgent relief supplies, including medicines to Ukraine
Updated On : 01 Mar 2022 | 8:07 AM IST

Dolo pill breaks sales record in pandemic as manufacturer makes a fortune

The Covid-19 pandemic has made several healthcare and pharma players billionaires and the makers of Dolo 650

Dolo pill breaks sales record in pandemic as manufacturer makes a fortune
Updated On : 20 Jan 2022 | 7:09 PM IST

Glenmark Pharma gets tentative FDA nod for generic Regadenoson injection

Glenmark Pharmaceuticals on Monday said its US arm has received tentative approval from the country's health regulator for its generic Regadenoson injection. Regadenoson injection is given during the preparation for a radiologic examination of blood flow through the heart to test for coronary artery disease. The tentative approval granted by the United States Food & Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc, USA (Glenmark) is for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the company said in a statement. It is the generic version of Lexiscan injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas US Inc, it added. Citing IQVIATM sales data for the 12 month period ending November 2021, the company said the Lexiscan Injection, 0.4 mg/5 mL (0.08 mg/mL) market achieved annual sales of approximately USD 659.9 million. The company said its current portfolio consists of 172 products authorized for distribution in the US marketplace and 47 .

Glenmark Pharma gets tentative FDA nod for generic Regadenoson injection
Updated On : 17 Jan 2022 | 10:34 AM IST

India's diabetes care market to reach $60 bn in next 10 yrs: Report

The diabetes care market in India is expected to reach about $60 billion in the next 10 years, from approximately $17 billion in FY2021, a new report said

India's diabetes care market to reach $60 bn in next 10 yrs: Report
Updated On : 13 Jan 2022 | 10:20 AM IST

Pharma firms to roll out anti-Covid pill as DCGI approves emergency use

Six other homegrown pharma companies announced rolling out their generic versions of the drug shortly

Pharma firms to roll out anti-Covid pill as DCGI approves emergency use
Updated On : 28 Dec 2021 | 11:10 PM IST

US adds Merck pill as second easy-to-use drug against Covid-19

The Food and Drug Administration authorization comes one day after the agency cleared a competing drug from Pfizer

US adds Merck pill as second easy-to-use drug against Covid-19
Updated On : 23 Dec 2021 | 10:56 PM IST

Keep buffer of 8 critical drugs for Covid treatment, Centre to states

The government said many ventilators supplied by the Centre were still lying unused at some field hospitals

Keep buffer of 8 critical drugs for Covid treatment, Centre to states
Updated On : 10 Dec 2021 | 12:44 AM IST

Dr. Reddy's inks pact with Singapore firm to sell Trastuzumab biosimilar

Prestige BioPharma Ltd announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and commercialisation of Trastuzumab biosimilar

Dr. Reddy's inks pact with Singapore firm to sell Trastuzumab biosimilar
Updated On : 09 Dec 2021 | 10:13 AM IST

Biocon ties up with Tabuk Pharmaceuticals to sell medicines in Middle East

Biocon said it has inked a pact with Saudi Arabia-based drug firm Tabuk Pharmaceutical Manufacturing Company to commercialise select speciality products in Middle East region

Biocon ties up with Tabuk Pharmaceuticals to sell medicines in Middle East
Updated On : 07 Dec 2021 | 12:36 PM IST

US overdose deaths topped 100,000 in one year, say officials

Overdose deaths have been rising for more than two decades, according to new data

US overdose deaths topped 100,000 in one year, say officials
Updated On : 17 Nov 2021 | 10:56 PM IST

Nobel Prize in medicine for discovery of temperature, touch receptors

The Nobel Prize in the field of physiology or medicine has been awarded to US scientists David Julius and Ardem Patapoutian.

Nobel Prize in medicine for discovery of temperature, touch receptors
Updated On : 05 Oct 2021 | 2:22 AM IST

Medicine delivery by drones to be piloted in 16 green zones in Telangana

Jyotiradtiya Scindia said the Medicines from the Sky project under which drugs and vaccines are delivered using drones, will be taken up on a pilot basis in 16 green zones in Telangana

Medicine delivery by drones to be piloted in 16 green zones in Telangana
Updated On : 11 Sep 2021 | 10:22 PM IST

Govt revises NLEM: Slashes prices of 39 commonly used medicines

Revising the 'National List of Essential Medicines', the central govenrment has slashed the prices of 39 commonly used drugs.

Govt revises NLEM: Slashes prices of 39 commonly used medicines
Updated On : 04 Sep 2021 | 1:06 PM IST

Lupin gets tentative nod from USFDA to market partial-onset seizures drug

Drug firm Lupin on Monday said it has received tentative nod from the US health regulator to market its generic Brivaracetam tablets used for the treatment of partial-onset seizures

Lupin gets tentative nod from USFDA to market partial-onset seizures drug
Updated On : 16 Aug 2021 | 7:55 PM IST

Production capacity of Remdesivir ramped up by more than 3-times

India now has capacity to manufacture 12.25 mn vials a month

Production capacity of Remdesivir ramped up by more than 3-times
Updated On : 05 Aug 2021 | 12:56 PM IST

Govt creating 30-day stock of key Covid drugs ahead of anticipated 3rd wave

State governments like Rajasthan and Gujarat, too, are trying to pile up the stock of other essential medicines

Govt creating 30-day stock of key Covid drugs ahead of anticipated 3rd wave
Updated On : 19 Jul 2021 | 6:10 AM IST

Lesson learnt hard, states in preparation mode for possible 3rd Covid wave

Building capacity with oxygen plants and concentrators, beds, ventilators, paediatric facilities, nurses, doctors

Lesson learnt hard, states in preparation mode for possible 3rd Covid wave
Updated On : 16 Jul 2021 | 6:10 AM IST

Ramdev has no ill-will against modern science, its practitioners: Patanjali

Patanjali Yogpeeth Trust denied allegations by the Indian Medical Association (IMA) that yoga guru Ramdev has misled people by making "unlearned" statements modern medicine

Ramdev has no ill-will against modern science, its practitioners: Patanjali
Updated On : 22 May 2021 | 8:47 PM IST